Structured evidence table for Bifidobacterium Longum Sleep Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Bifidobacterium Longum Sleep Randomized Trial | Twenty RCTs were included, of which 15 were assessed as having a low risk of bias and five as having a high risk of bias. | 1 | Das M (2026) | From Gut to Mind: Impact of Probiotics on Depression, Anxiety, Mood, Gut Microbiota, Sleep and Stress-A Systematic Review of RCTs. |
| Bifidobacterium Longum Sleep Randomized Trial | Overall, probiotics were associated with improvements in depression, anxiety, sleep quality, mood, cognition, quality of life, and beneficial gut microbial populations, although findings for cortisol and stress-related outcomes were inconsistent. | 1 | Das M (2026) | From Gut to Mind: Impact of Probiotics on Depression, Anxiety, Mood, Gut Microbiota, Sleep and Stress-A Systematic Review of RCTs. |
| Bifidobacterium Longum Sleep Randomized Trial | Background Probiotic supplementation may influence mental health through the gut-brain axis, with potential effects on depression, anxiety, sleep, cognition, stress hormones, and gut microbial composition. | 1 | Das M (2026) | From Gut to Mind: Impact of Probiotics on Depression, Anxiety, Mood, Gut Microbiota, Sleep and Stress-A Systematic Review of RCTs. |
| Bifidobacterium Longum Sleep Randomized Trial | This systematic review aimed to evaluate the effects of probiotics on psychological, physiological, and gut microbiome-related outcomes across diverse populations. | 1 | Das M (2026) | From Gut to Mind: Impact of Probiotics on Depression, Anxiety, Mood, Gut Microbiota, Sleep and Stress-A Systematic Review of RCTs. |
| Bifidobacterium Longum Sleep Randomized Trial | Among the measured SCFAs, only the butyric acid concentration in PG increased significantly during supplementation (baseline vs. | 2 | Drzymała S (2026) | The Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial. |
| Bifidobacterium Longum Sleep Randomized Trial | Background : Recovering from COVID-19 does not always lead to complete recovery, and many patients report symptoms of anxiety and depression. | 2 | Drzymała S (2026) | The Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial. |
| Bifidobacterium Longum Sleep Randomized Trial | The aim of this study was to evaluate the impact of psychobiotic therapy on the effectiveness of treating anxiety and depressive symptoms in individuals who had previously experienced COVID-19. | 2 | Drzymała S (2026) | The Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial. |
Source documents